Another recent study by Baird et al. incorporated a STING ligand into a hydrogel (Matrigel) and injected it intratumourally in HNSCC tumours resected from mice to demonstrate anti-tumour activity in comparison to controls [44]. Here, STING1 is linked to head and neck squamous cell carcinoma.